Nephros (NEPH) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $5.2 million.
- Nephros' Cash & Equivalents rose 11045.99% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 11045.99%. This contributed to the annual value of $3.8 million for FY2024, which is 1270.03% down from last year.
- According to the latest figures from Q3 2025, Nephros' Cash & Equivalents is $5.2 million, which was up 11045.99% from $5.1 million recorded in Q2 2025.
- Nephros' 5-year Cash & Equivalents high stood at $8.3 million for Q2 2021, and its period low was $2.5 million during Q3 2024.
- For the 5-year period, Nephros' Cash & Equivalents averaged around $4.8 million, with its median value being $4.2 million (2022).
- In the last 5 years, Nephros' Cash & Equivalents tumbled by 4951.68% in 2022 and then soared by 11045.99% in 2025.
- Nephros' Cash & Equivalents (Quarter) stood at $7.0 million in 2021, then tumbled by 47.88% to $3.6 million in 2022, then rose by 18.52% to $4.3 million in 2023, then dropped by 12.7% to $3.8 million in 2024, then soared by 37.53% to $5.2 million in 2025.
- Its Cash & Equivalents stands at $5.2 million for Q3 2025, versus $5.1 million for Q2 2025 and $4.1 million for Q1 2025.